Carefully targeted cooperative arrangements and acquisitions play a central role alongside our own research and development activities in putting this growth strategy into practice. Our R&D department quickly combines the technologies contributed by our partners with our own components to create innovative new products.
Sartorius Stedim Biotech’s strong dedicated sales, distribution, and service organizations and manufacturing companies give it a global presence with a particularly high profile in the major pharmaceutical markets. All of the products and services offered to our customers, most of which are themselves international companies, from our various production facilities around the world meet the same global quality standards.
Strongly rooted in the scientific community and closely allied with customers and technology partners, Sartorius Stedim Biotech is dedicated to its philosophy of “turning science into solutions.”
Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America, and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs nearly 2,600 people, and in 2010 earned sales revenue of €432.9 million.